Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

toothbrush

- PMLiVE

Valeant lead bidder for troubled Dendreon

Willing to pay $296m for company behind prostate cancer vaccine Provenge

- PMLiVE

ICON to open global innovation hub in Ireland

Will create 200 new jobs

Eli Lilly HQ

Lilly eyes pivotal trials for pain drug tanezumab in 2015

Drug was placed under clinical hold by FDA in 2010

- PMLiVE

FDA approves BMS’ Evotaz for HIV

 Combines Reyataz with Gilead’s boosting agent cobicistat  

- PMLiVE

Shire gets FDA nod for first binge-eating treatment

Vyvanse already available as ADHD treatment

- PMLiVE

New associate director at Packer Forbes

Samantha Bremner joins from Wave Healthcare Communications

- PMLiVE

NICE consults on reducing melanoma cases

New guidance set to focus on diagnosing and managing the skin cancer  

Roche Basel Switzerland

Roche’s newer breast cancer drugs gain traction

Perjeta and Kadcyla boost 2014 revenues

- PMLiVE

Imbruvica gets FDA OK for rare lymphoma

Cancer drug available in US to treat Waldenström's macroglobulinaemia          

Biogen Idec building

Biogen Idec plans phase III Alzheimer’s trial before year-end

And MS drugs drive 2014 sales          

- PMLiVE

The FDA will not regulate your Apple Watches and Fitbits

US regulator clarifies its health wearables stance in draft guidance

Algeta execs join Targovax

Anna-Kirsti Aksnes and Tina Madsen join the firm

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links